Phase IIb REGENESIS

Related by string. * phases . Phases . phase . PHASE . PHASES : Phase III clinical trials . Phase III trials . Phase III clinical . Phase 2b clinical / IIB . IIBS : Phase IIb clinical . initiate Phase IIb . glycoprotein GP IIb IIIa . glycoprotein IIb IIIa inhibitors / ReGenesis . Regenesis : modified REGENESIS Phase IIb . Regenesis Power . REGENESIS Phase IIb . Regenesis Biomedical * *

Related by context. Frequent words. (Click for all words.) 63 NTx TM -# 57 Phase Ib IIa 56 phase IIb clinical 55 DP b# 55 Alfimeprase 55 Cerovive 54 motesanib 54 phase IIa clinical 54 recurrent glioblastoma multiforme 54 senicapoc 53 non valvular atrial 53 IMC #B 53 GGF2 52 pertuzumab 52 GRNVAC1 52 double blinded placebo 52 muraglitazar 52 placebo controlled clinical 52 ABSORB trial 52 MKC# 52 REG1 52 Desmoteplase 51 cortical stimulation 51 Phase IIa trials 51 metastatic hormone refractory 51 Dabigatran 51 Proxinium TM 51 Phase IIb clinical trials 51 Trofex 51 phase IIa 51 SUCCEED trial 51 oral deforolimus 50 GRNCM1 50 olmesartan 50 cilostazol 50 blinded placebo controlled 50 stereotactic body 50 dose escalation clinical 50 Randomized controlled 50 cerebrovascular events 50 Phase IIb clinical 50 confirmatory Phase III 50 R sorafenib tablets 50 Cloretazine R VNP#M 50 TACI Ig 50 thrombolytic therapy 50 Allovectin 7 ® 50 Phase IIb 50 figitumumab 50 Phase Ib II 49 multicenter Phase 49 ICA # 49 ongoing Phase 1b 49 LibiGel Phase III 49 pamidronate 49 Canvaxin 49 ischemic cardiomyopathy 49 fenretinide 49 varespladib 49 Daclizumab 49 forodesine 49 Phase Ib clinical 49 tissue plasminogen activator tPA 49 placebo controlled randomized 49 multicenter clinical 49 nonsmall cell lung cancer 49 Diamyd ® 49 SEPET TM 49 teriflunomide 49 elotuzumab 49 carotid stent 49 multicenter prospective 49 pharmacodynamic effects 49 Hydroxyurea 48 ThermoDox R 48 coronary intervention 48 acute coronary syndromes ACS 48 phase Ib 48 Mipomersen 48 GLPG# 48 metastatic castration resistant 48 cerebrovascular diseases 48 desmoteplase 48 double blinded randomized 48 CEQ# 48 blind multicenter 48 recurrent glioblastoma 48 Phase IIB 48 Asentar 48 rufinamide 48 Phase 1b trial 48 deforolimus 48 patients undergoing CABG 48 TOLAMBA 48 metreleptin 48 anti arrhythmic 48 GSK# [001] 48 OMS# 48 CMV vaccine 48 carotid artery stenting 48 MADIT II

Back to home page